Zhonghui Qi
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study.
Journal: Dermatology practical & conceptual
Published: July 16, 2023
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy.
Journal: Journal for immunotherapy of cancer
Published: December 07, 2022
Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
Journal: Journal of the American Academy of Dermatology
Published: June 19, 2022
Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Journal: The British journal of dermatology
Published: September 17, 2021
Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.
Journal: Frontiers in immunology
Published: March 14, 2021
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy-Ad hoc Analyses of Pooled Data From Two Clinical Trials.
Journal: Frontiers in oncology
Published: December 08, 2020
Palbociclib in advanced acral melanoma with genetic aberrations in the cyclin-dependent kinase 4 pathway.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 25, 2020
The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
Journal: Annals of surgical oncology
Published: November 17, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026